01 4Gowling WLG (Canada) LLP
01 12145985
02 12286330
03 12787952
04 12860941
01 4Bevacizumab
01 4Solution
01 12012-10-28
02 12018-04-03
03 12031-02-22
04 12033-03-11
Patent Expiration Date : 2018-04-03
Date Granted : 2008-06-10
Brand Name : AVASTIN
Patent Number : 2286330
Filing Date : 1998-04-03
Strength per Unit : 25mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2018-04-03
Date Granted : 2008-06-10
Patent Expiration Date : 2012-10-28
Date Granted : 2003-09-16
Brand Name : AVASTIN
Patent Number : 2145985
Filing Date : 1992-10-28
Strength per Unit : 25mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2012-10-28
Date Granted : 2003-09-16
Patent Expiration Date : 2031-02-22
Date Granted : 2016-07-26
Brand Name : AVASTIN
Patent Number : 2787952
Filing Date : 2011-02-22
Strength per Unit : 25mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2031-02-22
Date Granted : 2016-07-26
Patent Expiration Date : 2033-03-11
Date Granted : 2019-11-05
Brand Name : AVASTIN
Patent Number : 2860941
Filing Date : 2013-03-11
Strength per Unit : 25mg / ml
Dosage Form : Solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2033-03-11
Date Granted : 2019-11-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
